Xianle Health (300791.SZ) released its 2023 annual report. During the reporting period, the company achieved operating income of 3,582 million yuan, an increase of 42.87%; net profit attributable to shareholders of listed companies was 281 million yuan, an increase of 32.39%; net profit attributable to shareholders of listed companies deducted non-recurring profit and loss of 281 million yuan, an increase of 43.01% year on year; and basic earnings per share of 1.5585 yuan/share.
仙乐健康(300791.SZ)发2023年度业绩，净利润2.81亿元，同比增长32.39%
Xianle Health (300791.SZ) released 2023 annual results, with net profit of 281 million yuan, an increase of 32.39% over the previous year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.